Archive for the ‘AE37’ category

A Quick Backgrounder on Generex’s Ii-key Hybrid Vaccine AE37 for Breast Cancer

January 6th, 2010

As of lately a lot of Generex investors have been focusing on their lead product: Oral-Lyn, a buccal insulin delivery system for diabetics. But this morning the company announced that they would be issuing a 3 part white paper on their other products that they have in the pipeline. » Read more: A Quick Backgrounder on Generex’s Ii-key Hybrid Vaccine AE37 for Breast Cancer

3 comments »

Posted in AE37, Generex